[25] Thus, further studies will be required to determine the effects of NKT cells. Over the past decade, many studies have suggested that BM-derived cells migrating into fibrotic liver tissue promote liver fibrogenesis.[26-29] In mice and humans, BM-derived cells may transdifferentiate into collagen-producing myofibroblasts in hepatotoxin-induced mouse liver fibrosis model and in patients with hepatitis
virus-derived fibrosis.[26, 27] In addition, BM-derived fibrocytes also contribute to bile duct ligation-induced liver fibrosis in mice, while HSCs are not originated from BM cells.[28] Furthermore, adoptive transfer of Gr1+ monocyte subset isolated from BM cells promoted CCl4-treated liver fibrosis Lapatinib cost of mice via direct activation of HSCs in a TGF-β-dependent manner.[29] In contrast, other RGFP966 types of BM cells have shown to ameliorate liver fibrosis, which is discussed later. Recently, we and other groups have suggested that hepatic
NK cells play a negative regulatory role in liver fibrosis in mice.[30-33] During liver fibrogenesis, NK cells can interact with activated HSCs via retinoic acid early inducible gene-1/NKG2D- or activating/inhibitory killer immunoglobulin receptor/MHC class I-dependent manners,[30, 31] leading to kill or suppress activated HSCs by modulating the production of NK cell-mediated tumor necrosis factor-related ligand (TRAIL) and interferon-γ.[30, 32] Although NK cells inhibit liver fibrosis by producing IFN-γ, which induces HSC apoptosis and cell cycle arrest,[32] a clinical trial reported that treatment of IFN-γ showed no beneficial effects on patients with advanced liver fibrosis.[34] This
discrepancy was elucidated by our recent study that in contrast to early activated HSCs, intermediately activated HSCs in advanced liver fibrosis were resistant to this website NK cell killing and interferon-γ treatment because of retinoic acid-mediated TGF-β production and suppressor of cytokine signaling (SOCS) 1 expression of HSCs, respectively.[33] In addition, several papers show human NK cells kill human HSCs, thereby inhibiting liver fibrosis in patients.[35, 36] Isolated NK cells from HCV-infected patients efficiently induce apoptosis of activated HSCs in TRAIL-, FasL-, and NKG2D-dependent manners.[35] NKp46high NK cell subset potentially suppresses HCV replication and HCV-associated liver damage, leading to amelioration of liver fibrosis.[36] However, chronic alcohol consumption accelerates liver fibrosis by suppressing the anti-fibrotic effects of NK cell/interferon-γ.[37] Based on these studies, hepatic NK cells seem to have an anti-fibrotic role through interaction with HSCs. Nevertheless, the bidirectional interactions between HSCs and NK cells are still not fully understood, especially the reverse suppressive effects of HSCs against NK cells or the effects of retinol and its metabolites of HSCs on NK cells.